Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEACON: Brimonidine posterior segment DDS in geographic atrophy secondary to AMD
2013-003320-36Phase 2Completed
- Sponsor
- Allergan
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of brimonidine in age-related macular degeneration (AMD) (2 arms), sponsored by Allergan. Primary endpoint: Change in atrophic lesion area. Started Jun 2014; status: completed.
02
Drugs
brimonidine
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2013-003320-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003320-36.